[EIP 2015] Meningitis Surveillance & Vaccination Coverage Updates. Meningococcal B Vaccine Introduction Europe

Recorded: EIP 2015 ● Language: English ● Duration: 24 minutes Topic: Pediatric Infectious Diseases

     
 

Speaker: GEORGE A. SYROGIANNOPOULOS, Professor and Chairman of Paediatrics, School of Medicine, University of Thessaly, Greece

 
     
  Learning Objectives: At the end of the session participants will: (1) learn that currently Neisseria meningitides (meningococcus) and pneumococcus are the two most common etiologic agents of bacterial meningitis in Europe; (2) understand the overall burden of meningococcal disease and the role of the different meningococcal serogroups with serogroup B being the predominant one in Europe; (3) learn that recently, two new meningococcal serogroup B protein vaccines have been available; (4) learn that MenB-4C vaccine has been approved in Europe and universal vaccination of young infants has been initiated in the UK; and (5) understand the accumulating data on the immunogenicity, safety and effectiveness of MenB-4C vaccine in different areas of the world.  
         





Click on a tag to view other related posts

Showing 1 reaction

Please check your e-mail for a link to activate your account.

get updates

connect